semaglutide improves cv outcomes in patients with history of cabg and obesity | jacc | aha 2024
Published 9 days ago • 248 plays • Length 17:23Download video MP4
Download video MP3
Similar videos
-
15:20
step-hfpef program: semaglutide and nyha class in obesity-related hfpef | ada 2024
-
9:03
step-hfpef trials: efficacy of semaglutide by sex in obesity-related hfpef | ada 2024
-
2:18
semaglutide and cardiovascular outcomes in obesity | nejm
-
15:33
the most important glutamine transporter: slc7a11
-
5:30
glaukos - istent infinite animation procedure and scenarios
-
3:36
study finds semaglutide offers major heart benefits
-
3:29
semaglutide reduces cardiovascular risk in obesity without diabetes
-
48:35
semaglutide: from weight loss fad to protection in cad
-
2:05
semaglutide in heart failure with obesity | nejm
-
12:00
semaglutide saving lives in kidney disease
-
38:43
acc cardiology hour from aha 2022
-
2:40
the cellular actions of sglt2i's
-
17:07
reflux after weight loss surgery - medications, endoscopic therapies or bypass
-
2:00
outcomes for bypass surgery may improve using seaweed molecules
-
1:00
can semaglutide reduce cardiovascular events!? 🤔 #doctor #medicine #familymedicine
-
2:26
gastric bypass long-term metabolic benefit
-
0:54
train like never before: hyper-realistic endovascular simulator | surgeonslab ag
-
2:22
how long can you stay on semaglutide?